Physician
Otolaryngology (ENT)
Dr. Chad A. Glazer, MD
|
|
Give Review
Dr. Chad A. Glazer is an expert in the field of Otolaryngology (ENT). He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Chad Glazer is a published physician as well. He has 20 publications published. The latest was: MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma. Chad A. Glazer accepts Medicare payments and is registered with Medicare.gov.
Publications
- MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma.
- Dose-Dependent Activation of Putative Oncogene SBSN by BORIS.
- Multidisciplinary care of international patients with cleft palate using telemedicine.
- BORIS binding to the promoters of Cancer testis antigens, MAGEA2, MAGEA3 and MAGEA4, is associated with their transcriptional activation in lung Cancer.
- Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland Adenoid cystic carcinoma.
- The role of MAGEA2 in head and neck Cancer.
- TKTL1 is activated by promoter hypomethylation and contributes to Head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alp...
- Coordinated activation of candidate proto-oncogenes and Cancer testes antigens via promoter demethylation in head and neck Cancer and lung Cancer.
- Integrative discovery of epigenetically derepressed Cancer testis antigens in NSCLC.
- Pathology quiz case 1. Metastatic mesothelioma involving the tongue.
- Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
- EIF2C is overexpressed and amplified in Head and neck squamous cell carcinoma.
- Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity Cancer and premalignancy.
- Chronic cigarette smoke extract treatment selects for apoptotic dysfunction and mitochondrial mutations in minimally transformed oral keratinocytes.
- MicroRNA alterations in Head and neck squamous cell carcinoma.
- Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell Cancers of the head and neck.
- Head and neck Cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.
- Molecular techniques and genetic alterations in head and neck Cancer.
- Applying the molecular biology and epigenetics of head and neck Cancer in everyday clinical practice.
Schools
Johns Hopkins Univ Sch Of Med
Johns Hopkins University School of Medicine
Duke University
Procedures Preformed
- Ablation or Excision of Nasal Turbinates
- Antrostomy and Antrotomy (Sinus Surgery)
- Balloon Sinuplasty
- Blepharoplasty
- View All
Conditions Treated
- Acoustic Neuroma
- Acute Sinusitis
- Acute Tonsillitis
- Allergic Rhinitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1609915503 | |
| NPPES Provider LastName | GLAZER | |
| NPPES Provider FirstName | CHAD | |
| NPPES Provider ZIPCode | 463606312 | |
| NPPES Provider State | IN | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 448.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 5.36 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609915503 |
| Last Name Of The Provider | GLAZER |
| First Name Of The Provider | CHAD |
| View All |
Similar Doctors
|
Dr. David L. Colgrove, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard M. Carr, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Franklin Holzer, MD
This Doctor is OpenDoctor Recommended.
|